Relevant molecular markers and targets

This publication has 81 references indexed in Scilit:

• Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the “do ut des” paradigm)
  Critical Reviews in Oncology/Hematology, 2006
• Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway
  Cancer Research, 2006
• Targeting Aurora kinases in ovarian cancer
  Emerging Therapeutic Targets, 2006
• Effect of Epidermal Growth Factor Receptor Expression Level on Survival in Patients with Epithelial Ovarian Cancer
  Clinical Cancer Research, 2005
• Phosphatidylinostol 3-Kinase Mediates Angiogenesis and Vascular Permeability Associated with Ovarian Carcinoma
  Clinical Cancer Research, 2005
• Protein Expression and Prognostic Value of Genes in the erb-b Signaling Pathway in Advanced Ovarian Carcinomas
  American Journal of Clinical Pathology, 2005
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Expression of Epidermal Growth Factor-Related Proteins and Epidermal Growth Factor Receptor in Common Epithelial Ovarian Tumors
  International Journal of Gynecological Pathology, 1997
• Point Mutation of the ras Oncogene in Human Ovarian Cancer
  DNA and Cell Biology, 1993